The review will also highlight the latest research on APOC3 in diabetic populations, including longitudinal studies tracking its levels over time, in order to offer a more integrated understanding of its contribution to the cardiovascular risk in diabetes. This evidence concerns the gene APOC3 and diabetes mellitus.